|
Welcome back Rounds Table Listeners!
We are back today with our Classic Rapid Fire Podcast!
This week, Drs. John and Mike Fralick discuss two recent papers – one, exploring the use of rivaroxaban in rheumatic heart-disease associated atrial fibrillation, and the second investigating the effect of reduced-dose edoxaban on clinical outcomes in elderly individuals with atrial fibrillation. Two papers, here we go!
-
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Adults with Atrial Fibrillation (0:00 – 6:42).
-
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation (6:42 – 17:11).
And for the Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
The post Episode 46 – Anticoagulation in Atrial Fibrillation appeared first on Healthy Debate. |